278 related articles for article (PubMed ID: 7923978)
1. Clinical evaluation of the new, steam-sterilized polysulfone high-flux dialyzer.
Schaefer RM; Kulzer P; Gilge U; Schaefer L; Heidland A
Clin Nephrol; 1994 Jul; 42 Suppl 1():S21-5. PubMed ID: 7923978
[No Abstract] [Full Text] [Related]
2. Long-term experience with high-flux polysulfone in hemodialysis.
Civati G; Teatini U; Guastoni C; Perego A; Perrino ML; Ballerini L; Minetti L
Clin Nephrol; 1994 Jul; 42 Suppl 1():S26-30. PubMed ID: 7923979
[No Abstract] [Full Text] [Related]
3. Phosphate removal during dialysis--does the membrane matter?
Ritz E
Clin Nephrol; 1994 Jul; 42 Suppl 1():S57-60. PubMed ID: 7923986
[No Abstract] [Full Text] [Related]
4. Does an alteration of dialyzer design and geometry affect biocompatibility parameters?
Opatrný K; Krouzzecký A; Polanská K; Mares J; Tomsů M; Bowry SK; Vienken J
Hemodial Int; 2006 Apr; 10(2):201-8. PubMed ID: 16623675
[TBL] [Abstract][Full Text] [Related]
5. In vivo assessment of intact parathyroid hormone adsorption by different dialysis membranes during hemodialysis.
Balducci A; Coen G; Manni M; Perruzza I; Fassino V; Sardella D; Grandi F
Artif Organs; 2004 Dec; 28(12):1067-75. PubMed ID: 15554934
[TBL] [Abstract][Full Text] [Related]
6. The influence of cuprophan and polysulfone membranes on dialyzer reusability and intradialytic complications.
Kadiri S; Kehinde Z; Arije A; Salako BL
Afr J Med Med Sci; 2001 Sep; 30(3):191-4. PubMed ID: 14510127
[TBL] [Abstract][Full Text] [Related]
7. Comparison of aluminum removal between hemodialysis with polycarbonate low flux membrane and hemofiltration with polysulfone high flux membrane in end-stage renal failure patients.
Klemm A; Sperschneider H; Winnefeld K; Günther K; Stein G
Clin Nephrol; 1997 Feb; 47(2):133-4. PubMed ID: 9049466
[No Abstract] [Full Text] [Related]
8. Clinical experience with polysulfone: 10 years.
Vanholder R; Van Loo A; Ringoir S
Clin Nephrol; 1994 Jul; 42 Suppl 1():S13-20. PubMed ID: 7923977
[No Abstract] [Full Text] [Related]
9. Ultrafiltration using the polysulfone membrane to reduce the cytokine-inducing activity of contaminated dialysate.
Lonnemann G; Schindler R
Clin Nephrol; 1994 Jul; 42 Suppl 1():S37-43. PubMed ID: 7923982
[No Abstract] [Full Text] [Related]
10. Biocompatibility differences with respect to the dialyzer sterilization method.
Müller TF; Seitz M; Eckle I; Lange H; Kolb G
Nephron; 1998; 78(2):139-42. PubMed ID: 9496728
[TBL] [Abstract][Full Text] [Related]
11. Pulmonary hypertension in hemodialysis patients without arteriovenous fistula: the effect of dialyzer composition.
Kiykim AA; Horoz M; Ozcan T; Yildiz I; Sari S; Genctoy G
Ren Fail; 2010; 32(10):1148-52. PubMed ID: 20954973
[TBL] [Abstract][Full Text] [Related]
12. Thrombocytopenia associated with one type of polysulfone hemodialysis membrane: a report of 5 cases.
De Prada L; Lee J; Gillespie A; Benjamin J
Am J Kidney Dis; 2013 Jan; 61(1):131-3. PubMed ID: 23083811
[TBL] [Abstract][Full Text] [Related]
13. Single-dose pharmacokinetics of teicoplanin during hemodialysis therapy using high-flux polysulfone membranes.
Thalhammer F; Rosenkranz AR; Burgmann H; Graninger W; Hollenstein U; Schenk P; Thalhammer-Scherrer R; Traindl O; Hörl WH; Breyer S
Wien Klin Wochenschr; 1997 May; 109(10):362-5. PubMed ID: 9200809
[TBL] [Abstract][Full Text] [Related]
14. Comment on middle molecule removal in low-flux polysulfone dialyzers: impact of flows and surface area on whole-body and dialyzer clearances.
Polaschegg HD
Hemodial Int; 2006 Apr; 10(2):215-6; author reply 216. PubMed ID: 16623678
[No Abstract] [Full Text] [Related]
15. Enhanced long-term reduction of plasma leptin concentrations by super-flux polysulfone dialysers.
van Tellingen A; Grooteman MP; Schoorl M; ter Wee PM; Bartels PC; Schoorl M; van der Ploeg T; Nubé MJ
Nephrol Dial Transplant; 2004 May; 19(5):1198-203. PubMed ID: 14993491
[TBL] [Abstract][Full Text] [Related]
16. All high-flux membranes are equal but some high-flux membranes are less equal than others.
Vanholder R; Pedrini LA
Nephrol Dial Transplant; 2008 May; 23(5):1481-3. PubMed ID: 18305315
[No Abstract] [Full Text] [Related]
17. Differences in solute removal by two high-flux membranes of nominally similar synthetic polymers.
Ouseph R; Hutchison CA; Ward RA
Nephrol Dial Transplant; 2008 May; 23(5):1704-12. PubMed ID: 18156455
[TBL] [Abstract][Full Text] [Related]
18. [The treatment of hyperhomocysteinemia in patients on dialysis: folic acid or the high-flow polysulphonic membrane?].
Lovcić V; Kes P; Zeljko R; Kusec V
Acta Med Croatica; 2006 Jun; 60(3):201-8. PubMed ID: 16933832
[TBL] [Abstract][Full Text] [Related]
19. Granulocyte activation during hemodialysis.
Hörl WH; Riegel W; Steinhauer HB; Wanner C; Thaiss F; Bozkurt F; Haag M; Schollmeyer P
Clin Nephrol; 1986; 26 Suppl 1():S30-4. PubMed ID: 3829465
[TBL] [Abstract][Full Text] [Related]
20. Meltspun cellulose diacetate and polysulfone membranes have the same effect on complement activation and expression of leukocyte adhesion molecules and complement receptors.
Dameche L; Brunet P; George F; André-Pinon S; Bernard D; Sampol J; Berland Y
Nephrol Dial Transplant; 1995; 10 Suppl 10():33-8. PubMed ID: 8825430
[No Abstract] [Full Text] [Related]
[Next] [New Search]
